Clinical trials: Chin Augmentation
Chin Augmentation
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
- Trial name
- NCT07566286
- Testing
- Restylane Lyft with Lidocaine
- Where
- 8 sites in United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Chin Augmentation, Chin Retrusion
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
- Trial name
- NCT05777759
- Testing
- Restylane Lyft with Lidocaine, Juvederm Voluma XC
- Where
- 12 sites in United States, Puerto Rico
- Volunteers
- 175 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Esthetic
Effectiveness and Safety of STYLAGE® XXL for Chin Augmentation in Chinese Adults
The aim of this trial is to demonstrate the efficacy and safety of STYLAGE® XXL in augmenting the chin volume among Chinese adults.
- Trial name
- NCT05009381
- Testing
- Stylage XXL at enrollment, Stylage XXL at Month 6
- Where
- 5 sites in China
- Volunteers
- 174 people, healthy volunteers welcome
- Sponsor
- Laboratoires Vivacy
Aging, Healthy
The Evaluation of Efficacy and Safety of Stylage® XL Lidocaïne for the Restoration and/or Augmentation of Facial Volume
Stylage® XL Lidocaïne is a CE-marketed hyaluronic acid gel indicated for the restoration or augmentation of facial volume by injection into the deep dermis or subcutaneously.
- Trial name
- BeautyVolume (NCT04166292)
- Testing
- Stylage® XL Lidocaïne
- Where
- France
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Laboratoires Vivacy
Chin Augmentation
A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies
The study's main purpose is to evaluate the overall aesthetic improvement of the treated areas by treatment group, as assessed by the Investigator.
- Trial name
- ARTIST (NCT06428214)
- Testing
- Restylane Shaype, Restylane Defyne, Restylane Lyft lidocaine
- Where
- 3 sites in Canada
- Volunteers
- 45 people
- Sponsor
- Galderma R&D
Chin Retrusion, Chin Augmentation
A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion
To demonstrate the effectiveness of Restylane Defyne for chin augmentation and correction of chin retrusion by demonstrating the superiority in responder rates relative to no treatment.
- Trial name
- NCT03624816
- Testing
- Restylane Defyne
- Where
- 11 sites in United States
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Chin Retrusion
A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation
This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.
- Trial name
- NCT02833077
- Testing
- JUVÉDERM VOLUMA® XC
- Where
- 14 sites in United States
- Volunteers
- 221 people
- Sponsor
- Allergan
Chin Augmentation and Correction
New Dermal Filler for Chin Correction and Augmentation
Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GP0109 for augmentation and correction or retrusion in the chin region in Canada
- Trial name
- NCT04631263
- Testing
- Hyaluronic Acid
- Where
- 9 sites in Canada
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Galderma R&D